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FREQUENCIES OF VKORC1 G3730A GENETIC VARIANTS IN ISCHEMIC 
ATHEROTHROMBOTIC STROKE PATIENTS 
Garbuzova E.A., Dubovyk Ye.I., Ataman O.V. 
Sumy State University, Physiology and Pathophysiology Department 
Background. Vitamin K epoxide reductase (VKOR) is an integral membrane protein that 
catalyzes the reduction of vitamin K 2,3-epoxide and vitamin K to vitamin K hydroquinone, a cofactor 
required for the G-glutamyl carboxylation reaction. VKOR is highly sensitive to inhibition by 
warfarin, the most commonly prescribed oral anticoagulant. A lifelong decreased activity of the 
VKOR enzyme, however, might impair MGP activity and by this increase the risk of vascular 
calcification. The VKORC1 gene is located on the short arm of chromosome 16 (chromosomal 
location: 16p11.2). Polymorphisms in the VKORC1 could affect blood coagulation and other vitamin 
K-dependent proteins, such as osteocalcin, bone Gla protein, matrix Gla protein.  
Purpose. Study of frequencies of VKORC1 G3730A genetic variants in ischemic 
atherothrombotic stroke (IAS) patients. 
Materials and Methods. The study was conducted using venous blood of 170 patients with 
IAS (57,6% men and 42,4% women), the average age of 64,7±0,73 years. The control group consisted 
of 124 healthy donors, and the absence of cardiovascular diseases was confirmed through history, 
electrocardiogram data and arterial pressure measurements. DNA was isolated from it using a set of 
"Isogene" (Russia). The polymorphism G3730A (rs7294) was analyzed by amplification of a 500-bp 
sequence with the use of the following primers: sence – 5`-GTCCCTAGAAGGCCCTAGATGT-3`, 
antisense – 5`-GTGTGGCACATTTGGTCCATT-3`. The resultant polymerase chain reaction 
products were digested with BseNI (Thermo Scientific, USA), which yielded 2 DNA fragments of 
260 and 240 bp for the G allele on 2,5% agarose gel and only 1 band (500 bp) for the A allele. The 
results were worked out statistically using the official average of SPSS Statistics 17.0. For this 
purpose, reliability of differences was determined using χ 2 - test. The value of P < 0.05 was 
considered reliable. 
Results. Genotyping of the patients with IAS and comparing the results obtained with those 
of restriction analysis in the control group allowed to set that frequency of definite variants of this 
gene is statistically insignificant in G3730A polymorphism. It has been found that the ratio of 
homozygotes by the major allele, heterozygotes and homozygotes by the minor alleles in G3730A 
polymorphism constituted in patients with IAS: 31,8%, 50,0%, 18,2%; and in the control group it was 
36,3%, 50,8%, 12,9% (P = 0,423, χ2 = 1,721).   
Conclusions. No association has been found between the G3730A polymorphism of  
VKORC1 gene and ischemic atherothrombotic stroke in the patients from the northeastern region of 
Ukraine.  
 
ASSOCIATION TaqI POLYMORPHISM OF VDR GENE IN SMOKERS AND NON-
SMOKERS, AMONG PATIENTS WITH ISCHEMIC STROKE 
Obukhova О.А. 
Sumy State University, Physiology and Pathophysiology Department 
Study by WHO is shown that traditional approaches in the treatment of ischemic stroke are 
ineffective and lead to significant economic costs. The problem of low efficiency of health care 
activities is related to the absence of their etiological orientation due to insufficient understanding of 
the major mechanisms of formation of cerebrovascular disorders. It is projected that until 2030 
morbidity stroke will increase by 25%, due to the aging of the world population and increasing 
prevalence in the population of brain stroke risk factors like hypertension, heart disease, diabetes, 
physical inactivity, obesity, smoking, and others. 
The aim of our study was to analyze the association of TaqI polymorphism of VDR gene in 
smokers and non-smokers patients with atherothrombotic ischemic stroke. 
Venous blood of 170 patients with atherothrombotic ischemic stroke (AIS) and 124 healthy 
individuals (control group) was used for genotyping. Pathogenetic variants of stroke was determined 
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according to the criteria TOAST, based on anamnesis and clinical features of the disease, 
dopplerography ultrasound data of main arteries of the head, and ECG. Polymorphism TaqI of gene 
VDR was examined with PCR-RFLP methodology. 
The distribution of genotypes for TaqI polymorphic variant of VDR gene in smokers and non-
smokers was as follows. In the control group were found people, who do not smoke, with genotype 
T/T – 43.0%, with genotype T/t – 48.4%, with genotype t/t – 8.6%, and those who smoke, respectively 
45.1%, 35.5% and 19.4%. The comparison of the data indicates a lack of statistically significant 
differences in the distribution of genotypes of TaqI polymorphic variant between persons who are 
smokers and non-smokers in the control group (χ2=3,263, P=0,196). Among patients with AIS 
persons, non-smokers, with genotype T/T was 42.5% with genotype T/t – 46.7%, with genotype t/t – 
10.8%, and smokers – 34.0%, 52.0% and 14.0% respectively. Statistically significant differences in 
the distribution of SNP between the smokers and smokers with IAI is not found (χ2=1,146, P=0,564). 
In both groups, the main and control were not revealed assotiation between genotype and 
patients habit to the smoking. 
 
 
THE DISTRIBUTION OF GENOTYPES FOR THE А69314G POLYMORPHISM 
TNAP GENE IN THE CONTROL GROUP AND IN PATIENTS WITH ACUTE 
CORONARY SYNDROME 
 Rozumenko I.A., Forkert I.A., Garbuzova V.Yu. 
Sumy State University, Physiology and Pathophysiology Department 
Іntroduction. Tissue non-specific alkaline phosphatase (TNAP) promotes mineralization by 
hydrolysis inorganic phosphate (Pi) of inorganic pyrophosphate (РРі). Nowadays, there are more than 
3500 single-nucleotide polymorphisms of TNAP gene. Most researched such polymorphism 
appeared in connection with the TNAP gene mechanisms of calcification of the vascular wall, leading 
to the development of acute coronary syndrome. 
The purpose of the study. To investigate the distribution of genotypes for the А69314G 
polymorphism gene TNAP in healthy individuals and in patients with acute coronary syndrome 
(ACS). 
Materials and methods. Venous blood of 118 ACS patients were genotyped for the 
polymorphism by PCR. All statistical analyses were performed using the Statistical Package for 
Social Science program (SPSS for Windows, version 17.0). The χ2-test was used for comparison of 
the allele and genotype frequencies between different study subgroups. Differences were considered 
statistically significant with a P-value < 0.05.  
Discussion of results. From the analysis of the results of individual genotype frequencies for 
the А69314G polymorphism gene TNAP in the control group and in patients with ACS can be seen 
that in patients with ACS value homozygotes for the major allele (A/A), carriers of the minor allele 
(А/G+G/G) was 83,6% and 16,4%, while in the control group, the corresponding figures amounted 
to 69,5% and 30,5%. Differences in the distribution of different variants of genotype between patients 
with ACS and healthy patients go beyond statistical significance (χ2 = 6,302, P = 0,012). 
Conclusions. There is a significant difference in the distribution of genotypes for the А69314G 
polymorphism gene TNAP between healthy and sick persons with ACS. 
 
 
 
 
 
 
